Rights and permissions
About this article
Cite this article
Insulin aspart wins out over insulin glargine in China. Pharmacoecon. Outcomes News 619, 9 (2011). https://doi.org/10.2165/00151234-201106190-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106190-00028